UBS AM’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Sell |
49,595
-581
| -1% | -$24.5K | ﹤0.01% | 2169 |
|
|
2026
Q1 | $2.78M | Sell |
50,176
-1,805
| -3% | -$85.9K | ﹤0.01% | 1876 |
|
|
2025
Q4 | $1.94M | Buy |
51,981
+1,058
| +2% | +$43K | ﹤0.01% | 1889 |
|
|
2025
Q3 | $2.06M | Sell |
50,923
-39,734
| -44% | -$1.31M | ﹤0.01% | 1735 |
|
|
2025
Q2 | $2.32M | Buy |
90,657
+26,562
| +41% | +$579K | ﹤0.01% | 2084 |
|
|
2025
Q1 | $1.37M | Buy |
64,095
+1,529
| +2% | +$34.2K | ﹤0.01% | 2177 |
|
|
2024
Q4 | $1.31M | Buy |
62,566
+16,917
| +37% | +$391K | ﹤0.01% | 2242 |
|
|
2024
Q3 | $1.03M | Sell |
45,649
-15,608
| -25% | -$301K | ﹤0.01% | 2382 |
|
|
2024
Q2 | $1.03M | Buy |
61,257
+44,301
| +261% | +$712K | ﹤0.01% | 2356 |
|
|
2024
Q1 | $219K | Hold |
16,956
| – | – | ﹤0.01% | 2448 |
|
|
2023
Q4 | $196K | Hold |
16,956
| – | – | ﹤0.01% | 2492 |
|
|
2023
Q3 | $217K | Hold |
16,956
| – | – | ﹤0.01% | 2506 |
|
|
2023
Q2 | $260K | Hold |
16,956
| – | – | ﹤0.01% | 2515 |
|
|
2023
Q1 | $260K | Buy |
16,956
+3,878
| +30% | +$59.2K | ﹤0.01% | 2515 |
|
|
2022
Q4 | $175K | Hold |
13,078
| – | – | ﹤0.01% | 2460 |
|
|
2022
Q3 | $174K | Hold |
13,078
| – | – | ﹤0.01% | 2629 |
|
|
2022
Q2 | $250K | Hold |
13,078
| – | – | ﹤0.01% | 2524 |
|
|
2022
Q1 | $261K | Buy |
13,078
+3,144
| +32% | +$63.5K | ﹤0.01% | 2627 |
|
|
2021
Q4 | $203K | Hold |
9,934
| – | – | ﹤0.01% | 2760 |
|
|
2021
Q3 | $214K | Sell |
9,934
-8,085
| -45% | -$195K | ﹤0.01% | 2683 |
|
|
2021
Q2 | $520K | Buy |
18,019
+8,085
| +81% | +$219K | ﹤0.01% | 2522 |
|
|
2021
Q1 | $242K | Buy |
+9,934
| New | +$224K | ﹤0.01% | 2530 |
|
|
2020
Q3 | – | Sell |
-9,934
| Closed | -$261K | – | 2504 |
|
|
2020
Q2 | $261K | Hold |
9,934
| – | – | ﹤0.01% | 2321 |
|
|
2020
Q1 | $240K | Sell |
9,934
-300
| -3% | -$7.33K | ﹤0.01% | 2217 |
|
|
2019
Q4 | $254K | Sell |
10,234
-58
| -0.6% | -$1.35K | ﹤0.01% | 2410 |
|
|
2019
Q3 | $220K | Hold |
10,292
| – | – | ﹤0.01% | 2552 |
|
|
2019
Q2 | $327K | Hold |
10,292
| – | – | ﹤0.01% | 2378 |
|
|
2019
Q1 | $340K | Buy |
10,292
+1,134
| +12% | +$35.3K | ﹤0.01% | 2262 |
|
|
2018
Q4 | $295K | Hold |
9,158
| – | – | ﹤0.01% | 2221 |
|
|
2018
Q3 | $393K | Sell |
9,158
-4,463
| -33% | -$211K | ﹤0.01% | 2183 |
|
|
2018
Q2 | $627K | Buy |
13,621
+4,463
| +49% | +$198K | ﹤0.01% | 1997 |
|
|
2018
Q1 | $364K | Buy |
9,158
+9,100
| +15,690% | +$337K | ﹤0.01% | 2139 |
|
|
2017
Q4 | $1.94K | Hold |
58
| – | – | ﹤0.01% | 2552 |
|
|
2017
Q3 | $2.15K | Hold |
58
| – | – | ﹤0.01% | 2502 |
|
|
2017
Q2 | $2.15K | Hold |
58
| – | – | ﹤0.01% | 2487 |
|
|
2017
Q1 | $1.63K | Hold |
58
| – | – | ﹤0.01% | 2438 |
|
|
2016
Q4 | $2K | Buy |
+58
| New | +$1.58K | ﹤0.01% | 2448 |
|
|
2015
Q3 | – | Sell |
-6,000
| Closed | -$234K | – | 2690 |
|
|
2015
Q2 | $234K | Buy |
+6,000
| New | +$207K | ﹤0.01% | 2515 |
|
Other funds holding PAHC
UBS AM's PAHC Position: Q2 2026 in Review
UBS AM reduced its Phibro Animal Health (PAHC) stake by 1.2% in Q2 2026, selling an estimated $24.5K and leaving 49,595 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2169.
UBS AM first reported a position in PAHC in Q2 2015 and has held it in 38 quarters since. The position peaked at $2.78M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- UBS AM held 49,595 shares of Phibro Animal Health worth $1.56M as of Q2 2026.
- UBS AM sold 581 Phibro Animal Health shares in Q2 2026, an estimated $24.5K.
- Phibro Animal Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2169 holding.
- UBS AM first reported a position in Phibro Animal Health in Q2 2015 and has held it in 38 quarters since.
- UBS AM's Phibro Animal Health position peaked at $2.78M in Q1 2026.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.